Chapter 1 Prefix
    1.1 Market Scope
    1.2 Report Description
    1.3 Research Methodology
          1.3.1 Primary Research
          1.3.2 Secondary Research
          1.3.3 In-house Data Modeling
Chapter 2 Executive Summary
Chapter 3 Market Outline
    3.1 Market Inclination, Trend, Outlook and Viewpoint
    3.2 Market Share Analysis: Company’s Competitive Scenario
    3.3 Market Dynamics
          3.3.1 Drivers
                   3.3.1.1 Impact Analysis
          3.3.2 Restraints
                   3.3.2.1 Impact Analysis
          3.3.3 Opportunities
Chapter 4 Neurostimulation Devices Market by Device Type: Market Size and Forecast, 2015 – 2024
    4.1 Overview
    4.2 Implantable Devices
          4.2.1 Current Trend and Analysis
          4.2.2 Market Size and Forecast
          4.2.3 Cochlear Implants
          4.2.4 Cochlear Implants
          4.2.5 Deep Brain Stimulation
          4.2.6 Spinal Cord Stimulation
          4.2.7 Vagus Nerve Stimulation
          4.2.8 Gastric Electric Stimulation
          4.2.9 Others
    4.3 External Devices
          4.3.1 Current Trend and Analysis
          4.3.2 Market Size and Forecast
          4.3.3 Transcranial Magnetic Stimulation (TMS)
          4.3.4 Transcutaneous Electrical Nerve Stimulation (TENS)
          4.3.5 Others
Chapter 5 Neurostimulation Devices Market by Application: Market Size and Forecast, 2015 – 2024
    5.1 Overview
    5.2 Parkinson’s Disease
          5.2.1 Current Trend and Analysis
          5.2.2 Market Size and Forecast
    5.3 Pain Management
          5.3.1 Current Trend and Analysis
          5.3.2 Market Size and Forecast
    5.4 Epilepsy
          5.4.1 Current Trend and Analysis
          5.4.2 Market Size and Forecast
    5.5 Hearing Loss
          5.5.1 Current Trend and Analysis
          5.5.2 Market Size and Forecast
    5.6 Gastroparesis
          5.6.1 Current Trend and Analysis
          5.6.2 Market Size and Forecast
    5.7 Urinary and Fecal Incontinence
          5.7.1 Current Trend and Analysis
          5.7.2 Market Size and Forecast
    5.8 Depression
          5.8.1 Current Trend and Analysis
          5.8.2 Market Size and Forecast
    5.9 Others
          5.9.1 Current Trend and Analysis
          5.9.2 Market Size and Forecast
Chapter 6 Neurostimulation Devices Market by Geography: Market Size and Forecast, 2015 – 2024
    6.1 Overview
    6.2 North America
          6.2.1 Current Trend and Analysis
          6.2.2 Market Size and Forecast
          6.2.3 US
                   6.2.3.1 Market Size and Forecast
          6.2.4 Canada
                   6.2.4.1 Market Size and Forecast
          6.2.5 Mexico
                   6.2.5.1 Market Size and Forecast
    6.3 Europe
          6.3.1 Current Trend and Analysis
          6.3.2 Market Size and Forecast
          6.3.3 Germany
                   6.3.3.1 Market Size and Forecast
          6.3.4 France
                   6.3.4.1 Market Size and Forecast
          6.3.5 United Kingdom
                   6.3.5.1 Market Size and Forecast
          6.3.6 Others
                   6.3.6.1 Market Size and Forecast
    6.4 Asia-Pacific
          6.4.1 Current Trend and Analysis
          6.4.2 Market Size and Forecast
          6.4.3 China
                   6.4.3.1 Market Size and Forecast
          6.4.4 India
                   6.4.4.1 Market Size and Forecast
          6.4.5 Japan
                   6.4.5.1 Market Size and Forecast
          6.4.6 Others
                   6.4.6.1 Market Size and Forecast
    6.5 RoW
          6.5.1 Current Trend and Analysis
          6.5.2 Market Size and Forecast
          6.5.3 Middle East
                   6.5.3.1 Market Size and Forecast
          6.5.4 South America
                   6.5.4.1 Market Size and Forecast
          6.5.5 Africa
                   6.5.5.1 Market Size and Forecast
Chapter 7 Company Profiles
    7.1 DePuy Synthes Companies
    7.2 Cyberonics, Inc.
    7.3 Nevro Corporation
    7.4 St. Jude Medical, Inc.
    7.5 BioControl Medical
    7.6 Synapse Biomedical, Inc.
    7.7 Neuropace, Inc.
    7.8 Boston Scientific Corporation
    7.9 NDI Medical, LLC
    7.10 NeuroSigma, Inc.

GET MORE INFORMATION ABOUT THIS REPORT


Refresh Captcha

Related Report